721 Pixatimod (P) in combination with nivolumab (N) +/- low-dose cyclophosphamide (Cy) in advanced cancers: a phase IIA basket trial

Diwakar Davar; Hong Wang; Sarah Behr; Aubrey Murano; Sarah Johnson; Amy Rose; Darryn Bampton; Keith Dredge; Hassane Zarour; John Rhee; Liza Villaruz; Yana Najjar; Jason Luke

doi:10.1136/jitc-2022-SITC2022.0721

Article info

Regular and Young Investigator Award Abstracts

Clinical Trials In Progress

721 Pixatimod (P) in combination with nivolumab (N) +/- low-dose cyclophosphamide (Cy) in advanced cancers: a phase IIA basket trial

Free

Authors

Diwakar Davar UPMC Hillman Cancer Center, Pittsburgh, PA, USA PubMed articles Google scholar articles
Hong Wang University of Pittsburgh, Pittsburgh, PA, USA PubMed articles Google scholar articles
Sarah Behr UPMC Hillman Cancer Center, Pittsburgh, PA, USA PubMed articles Google scholar articles
Aubrey Murano UPMC Hillman Cancer Center, Pittsburgh, PA, USA PubMed articles Google scholar articles
Sarah Johnson UPMC Hillman Cancer Center, Pittsburgh, PA, USA PubMed articles Google scholar articles
Amy Rose UPMC Hillman Cancer Center, Pittsburgh, PA, USA PubMed articles Google scholar articles
Darryn Bampton Zucero, Brisbane, Australia PubMed articles Google scholar articles
Keith Dredge Zucero, Brisbane, Australia PubMed articles Google scholar articles
Hassane Zarour UPMC Hillman Cancer Center, Pittsburgh, PA, USA PubMed articles Google scholar articles
John Rhee UPMC Hillman Cancer Center, Pittsburgh, PA, USA PubMed articles Google scholar articles
Liza Villaruz UPMC Hillman Cancer Center, Pittsburgh, PA, USA PubMed articles Google scholar articles
Yana Najjar UPMC Hillman Cancer Center, Pittsburgh, PA, USA PubMed articles Google scholar articles
Jason Luke UPMC Hillman Cancer Center, Pittsburgh, PA, USA PubMed articles Google scholar articles

Citation

Davar D, Wang H, Behr S, et al

721 Pixatimod (P) in combination with nivolumab (N) +/- low-dose cyclophosphamide (Cy) in advanced cancers: a phase IIA basket trial

Journal for ImmunoTherapy of Cancer 2022;10:doi: 10.1136/jitc-2022-SITC2022.0721

Publication history

First published November 7, 2022.

Online issue publication

April 26, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password